✦ LIBER ✦

Predictive factors of response and survival among chronic myelomonocytic leukemia patients treated with azacitidine

✍ Scribed by Adès, Lionel; Sekeres, Mikkael A.; Wolfromm, Alice; Teichman, Melissa L.; Tiu, Ramon V.; Itzykson, Raphael; Maciejewski, Jaroslaw P.; Dreyfus, Francois; List, Alan F.; Fenaux, Pierre; Komrokji, Rami S.

Book ID: 123463783
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 294 KB
Volume: 37
Category: Article
ISSN: 0145-2126
DOI: 10.1016/j.leukres.2013.01.004

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

EUTOS score predicts survival and cytoge

EUTOS score predicts survival and cytogenetic response in patients with chronic phase chronic myeloid leukemia treated with first-line imatinib

✍ Tao, Zhongfei; Liu, Bingcheng; Zhao, Yaozhong; Wang, Ying; Zhang, Rongli; Han, M 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 621 KB

Predictive factors for successful imatin

Predictive factors for successful imatinib cessation in chronic myeloid leukemia patients treated with imatinib

✍ Lee, Sung-Eun; Choi, Soo Young; Bang, Ju-Hee; Kim, Soo-Hyun; Jang, Eun-jung; Bye 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 598 KB

P-301 Results of 5-azacitidine therapy i

P-301 Results of 5-azacitidine therapy in patients with myelodysplastic syndromes (MDS), chronic myelomonocytic leukemia (CMML) and acute myeloid leukemia (AML)

✍ Freyrie, A.; Reda, G.; Vincenti, D.; Ferla, V.; Orofino, N.; Sciumè, M.; Guidott 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 86 KB

Rapid loss of response after withdrawal

Rapid loss of response after withdrawal of treatment with azacitidine: a case series in patients with higher-risk myelodysplastic syndromes or chronic myelomonocytic leukemia

✍ Voso, Maria Teresa; Breccia, Massimo; Lunghi, Monia; Poloni, Antonella; Niscola, 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 101 KB

Comparison of various criteria in predic

Comparison of various criteria in predicting treatment response and prognosis of patients with myelodysplastic syndrome treated with azacitidine

✍ Dae-Young Kim; Je-Hwan Lee; Jung-Hee Lee; Kyoo-Hyung Lee; Yoe-Kyeoung Kim; Jae S 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 136 KB

KIR2DS1 genotype predicts for complete c

KIR2DS1 genotype predicts for complete cytogenetic response and survival in newly diagnosed chronic myeloid leukemia patients treated with imatinib

✍ Marin, D; Gabriel, I H; Ahmad, S; Foroni, L; Lavallade, H de; Clark, R; O'Brien, 📂 Article 📅 2011 🏛 Nature Publishing Group 🌐 English ⚖ 349 KB